Is Dalargin FDA approved?

Dalargin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Davunetide FDA approved?

Davunetide is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

How is Dalargin administered in research settings?

In research settings, Dalargin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

How is Davunetide administered in research settings?

In research settings, Davunetide is typically administered via the intranasal or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Dalargin vs Davunetide

Peptide Comparison

Dalargin vs Davunetide

Q: What is the difference between Dalargin and Davunetide?

Dalargin: Binds delta and mu opioid receptors with peripheral preference due to limited CNS penetration. Davunetide: Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

Both are Neuro & Cognitive peptides.

Dalargin

Leu-enkephalin-Arg

RecoveryNot EvaluatedResearch Only

No providers listed yet

Full Dalargin profile →

Davunetide

NAP

CognitiveInvestigationalResearch Only

No providers listed yet

Full Davunetide profile →

Bottom line

Davunetide carries stronger published evidence (RCT, 3 key studies) than Dalargin (Animal, 1); both are research compounds.

Quick Verdict

Dalargin

Evidence

Preclinical

Davunetide

Evidence

Clinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Davunetide
Further along in FDA review	Davunetide

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Dalargin

Davunetide

Mechanism Family

Neuro & Cognitive

Half-life

—

FDA Status

not evaluated

investigational

Admin Routes

subcutaneous, intravenous

intranasal, subcutaneous

Availability

Research Only

Providers

None listed

Research Evidence

Dalargin

PreclinicalAnimal · 1 key study · dated evidence base — most recent 2009

Davunetide

ClinicalRCT · 3 key studies · most recent 2026

Research Citations

Dalargin

Animal2009 · Bulletin of Experimental Biology and Medicine

Gastroprotective effect of dalargin in gastropathy due to treatment with nonsteroid antiinflammatory drugs

Davunetide

Cohort2026 · Epilepsy Res

Microtubule-stabilizing drugs suppress convulsions in a C. elegans model of CAMSAP disorders.

RCT2013 · Neuropsychopharmacology

Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with sch…

RCT2011 · Schizophrenia Research

Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophren…

About Dalargin

Binds delta and mu opioid receptors with peripheral preference due to limited CNS penetration. Reduces gastric acid secretion, promotes mucosal blood flow, and inhibits ulcer formation via prostaglandin-mediated pathways.

Research Areas

gastroprotectionGI repairanti-ulcerpain modulation

About Davunetide

Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

Research Areas

neuroprotectiontau stabilizationcognitive enhancementmemorysynaptic plasticity

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Dalargin

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Davunetide

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Dalargin

Browse directory →

Providers offering

Davunetide

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.